Of these are subunits and interactors of receptor complexes considered central to synaptic plasticity phenotypes associated with FXS, chiefly the of metabotropic glutamate receptor 5 (mGluR5) and N-methyl-D-aspartate (NMDA) receptor signalling complexes [19]. This evidence concerns the gene GRM5 and fragile X syndrome.